Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Adenocarcinoma Without Neuroendocrine Differentiation”

2 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 2 of 2 results

Testing effectiveness (Phase 2)Ended earlyNCT03570476
What this trial is testing

Olaparib Before Surgery in Treating Participants With Localized Prostate Cancer

Who this might be right for
Prostate Adenocarcinoma Without Neuroendocrine DifferentiationStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8+3 more
University of Washington 2
Testing effectiveness (Phase 2)Ended earlyNCT03360721
What this trial is testing

Apalutamide, Abiraterone Acetate, and Prednisone in Treating Participants With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaProstate Adenocarcinoma Without Neuroendocrine DifferentiationStage IV Prostate Cancer AJCC v8+2 more
M.D. Anderson Cancer Center 7